Abstract: A storage box and storage box system that has connectors to connect horizontally and vertically adjacent storage boxes. A lid of the boxes is releasably retained to the body via hinge members that selectively hinge the lid such that the lid can be opened from different sides of the body Furthermore, the lid can be removed entirely, should it be desired, by unlocking all hinge members. The storage boxes can have a liner to provide thermal insulation.

Abstract: Disclosed embodiments provide a bowtie clip that fits comfortably against the neck of a wearer. Bowtie clips in accordance with disclosed embodiments can include a front portion that comprises a flat surface. A first clip is attached to the front portion, where the first clip includes a first gripping element and a second gripping element. Similarly, a second clip is attached to the front portion. The second clip can be substantially similar to the first clip. The second clip can also include a first gripping element and a second gripping element. The first clip and second clip can clip on to the collar tabs of a shirt in order to secure the bowtie to a shirt.

Abstract: An electronic data analysis method including at least one server, comprising the steps of: a) Receiving, from an electronic device associated with a user to an electronic data analysis system, a search query including one or more search query terms; b) Maintaining an electronic search term database comprising a plurality of search terms; c) Identifying one or more relevant search terms from the plurality of search terms in the electronic search term; d) Sending, using the electronic data analysis system, a search request related to the one or more relevant search terms to a plurality of data sources external to the electronic data system; e) Receiving data associated with the one or more relevant search terms from the plurality of data sources; f) Assigning the data retrieved from the plurality of data sources into a plurality of data visualisation categories; and g) Displaying the plurality of data visualisation categories on the electronic device.

Abstract: A method of product distribution comprising using at least one hardware processor to: generating a plurality of venue offers including at least one or more brands of alcohol; obtaining a selection of a venue offer from the plurality of venue offers; and based on the selection, activating one or more customer offers corresponding to the one of the plurality of venue offers.

Abstract: The present invention provides novel compounds of Formulas (I) and (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: Systems and methods for measuring hemoglobin, G6PD activity, and or bilirubin activity in a sample, including measuring the absorbance of a sample, removing background interfering signals, and quantifying the relevant analyte. Systems and methods for reconstituting a reagent in a droplet actuator. Systems and methods for separating plasma from a whole blood sample on a droplet actuator, including combining a sample droplet with an agglutination reagent droplet and using a novel combination of droplet operations to split the sample into a plasma and an agglutinated red blood cell fraction.

Abstract: The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: Networks of superharmonic injection-locked (SHIL) electronic oscillators can be used to emulate Ising machines for solving difficult computational problems. The oscillators can be simulated or implemented in hardware (e.g., with LC oscillators) and are coupled to each other with links whose connection strengths are weighted according to the problem being solved. The oscillators' phases may be measured with respect to reference signal(s) from one or more reference oscillators, each of which emits a reference signal but does not receive input from any other oscillator. Sparsely connected networks of SHIL oscillators and reference oscillators can be used as Viterbi decoders that do not suffer from the information bottleneck between logic computational blocks and memory in digital computing systems.

Abstract: Alloys of GeSbSeTe (GSST) can be used to make actively tunable infrared transmission filters that are small, fast, and solid-state. These filters can be used for hyperspectral imaging, 3D LIDAR, portable bio/chem sensing systems, thermal emission control, and tunable filters. GSST is a low-loss phase-change material that can switch from a low-index (n=3), amorphous state to a high-index (n=4.5), hexagonal state with low loss (k<0.3) over a wavelength range of 2-10 microns or more. The GSST thickness can be selected to provide pure phase modulation, pure amplitude modulation, or coupled phase and amplitude modulation. GSST can be switched thermally in an oven, optically with visible light, or electrically via Joule heating at speeds from kilohertz to Gigahertz. It operates with reversible and polarization independent transmission switching over a wide incident angle (e.g., 0-60 degrees).

Abstract: The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: The present invention provides novel compounds of Formulas (I) and (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: The present invention provides novel compounds of Formulas (I) and (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: Networks of superharmonic injection-locked (SHIL) electronic oscillators can be used to emulate Ising machines for solving difficult computational problems. The oscillators can be simulated or implemented in hardware (e.g., with LC oscillators) and are coupled to each other with links whose connection strengths are weighted according to the problem being solved. The oscillators' phases may be measured with respect to reference signal(s) from one or more reference oscillators, each of which emits a reference signal but does not receive input from any other oscillator. Sparsely connected networks of SHIL oscillators and reference oscillators can be used as Viterbi decoders that do not suffer from the information bottleneck between logic computational blocks and memory in digital computing systems.

Abstract: The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.

Abstract: Alloys of GeSbSeTe (GSST) can be used to make actively tunable infrared transmission filters that are small, fast, and solid-state. These filters can be used for hyperspectral imaging, 3D LIDAR, portable bio/chem sensing systems, thermal emission control, and tunable filters. GSST is a low-loss phase-change material that can switch from a low-index (n=3), amorphous state to a high-index (n=4.5), hexagonal state with low loss (k<0.3) over a wavelength range of 2-10 microns or more. The GSST thickness can be selected to provide pure phase modulation, pure amplitude modulation, or coupled phase and amplitude modulation. GSST can be switched thermally in an oven, optically with visible light, or electrically via Joule heating at speeds from kilohertz to Gigahertz. It operates with reversible and polarization independent transmission switching over a wide incident angle (e.g., 0-60 degrees).

Abstract: Devices, systems, and methods for volumetrically measuring syringe fluid are disclosed. In one aspect, a device for volumetrically measuring syringe fluid includes a reference plate, a flange adapter base attached at a first end of the reference plate for receiving a flange of a syringe, a plunger adapter disposed adjacent to a housing for receiving a plunger of the syringe, the plunger adapter being configured to slidingly move along a length of the reference plate, a displacement sensor disposed in the housing and configured to measure a displacement of the plunger adapter in relation to the flange adapter base as the plunger adapter is slid along the length of the reference plate, and a displacement conversion mechanism disposed in the housing and configured to convert the displacement measurement of the plunger adapter to a volumetric measurement in order to determine a volume of fluid the syringe has drawn in.

Abstract: The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angiogenesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject.